Day: July 1, 2020

The global leader in the pool and wellness equipment business reaches a deal to acquire the Belgium based distributor of pool products.The purchase price places the equity value of Aquafive at approximately 4.8 million euros, with an immediate payment of 3.3 million euros and three annual deferred payments of 0.5 million euros.1st July 2020 – Fluidra, the global leader in the pool and wellness equipment business, has acquired one hundred percent of the capital of the Belgian distributor of pool products Aquafive. Both companies share a longstanding relationship in the past, Aquafive being the exclusive distributor of Zodiac branded products distributing in the Benelux region.The purchase price places the equity value of Aquafive, and its subsidiary Pentagone, at approximately 4.8 million euros. The price will be settled by an initial...

ISELIN, N.J., July 01, 2020 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX), a provider of water, wastewater and related services, announced today it has been selected as one of the Top Workplaces in New Jersey by NJ.com. The list of top New Jersey workplaces is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage, LLC. The anonymous survey uniquely measures 15 drivers of engaged cultures, which are critical to the success of any organization—including alignment, execution and connection.“In times of great change, it is more important than ever to maintain a connection among employees,” said Eric Rubino, Energage CEO. “When you give your employees a voice, you come together to navigate challenges and shape your path forward based on real-time...

Communiqué de PresseFin du programme de conversiondes OC émises en 2019 Dijon, le 1er juillet  2020CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence, annonce la fin du programme de conversion des obligations convertibles (OC) émises en  décembre 2019.Les obligations convertibles émises en décembre 2019 ont été intégralement converties. Ces conversions ont permis à Crossject de renforcer ses fonds propres pour un montant de 5,7 M€ par création de 3 680 612 actions.La conversion de la totalité des OC avant son terme, initialement prévu au 31 décembre 2021, illustre une nouvelle fois la confiance des investisseurs européens qui avaient souscrit à cette émission, et de Gemmes Venture, par ailleurs actionnaire historique...

Société anonyme au capital de 13 113 261,52 eurosSiège social : 16, rue de la Ville l’Evêque – 75008 Paris342 376 332 R.C.S. PARIS                                                                            Paris, le 1er juillet 2020Communiqué établissant le bilan semestrieldu contrat de liquidité entre ILIAD et NATIXIS ODDO BHFAu titre du contrat de liquidité confié par ILIAD à NATIXIS ODDO BHF, à la date du 30/06/2020 les ressources suivantes figuraient au compte de liquidité dédié :Il est rappelé qu’à la date de signature du contrat, les ressources suivantes figuraient au compte de liquidité dédié :Sur la période du 02 /01/2020 au 30 /06/2020 ont été exécutés :Sur cette même période, les volumes échangés ont représenté :A propos du Groupe iliadLe Groupe iliad est devenu en 20 ans un acteur majeur des télécommunications en France...

               Albion Venture Capital Trust PLCLEI number: 213800JKELS32V2OK421As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rules 4.1 and 6.3, Albion Venture Capital Trust PLC today makes public its information relating to the Annual Report and Financial Statements for the year ended 31 March 2020.This announcement was approved for release by the Board of Directors on 1 July 2020.This announcement has not been audited.The Annual Report and Financial Statements for the year ended 31 March 2020 (which have been audited), will shortly be sent to shareholders. Copies of the full Annual Report and Financial Statements will be shown via the Albion Capital Group LLP website by clicking www.albion.capital/funds/AAVC/31Mar2020.pdf.The information contained in the Annual Report and Financial Statements will...

Sandoz evaluating next steps, including potential appeal to US Supreme Court Ruling continues to prevent launch of important, affordable treatment option for US patients affected by chronic autoimmune and inflammatory diseases Sandoz remains deeply committed to making Erelzi available to US patients as soon as possible, contributing to a more sustainable healthcare systemHolzkirchen, Germany, July 1, 2020 – Sandoz, a Novartis division and a global leader in biosimilars, today announced that the US Court of Appeals for the Federal District has ruled against Sandoz in patent litigation concerning the Sandoz biosimilar Erelzi® (etanercept-szzs) for reference medicine Enbrel®* (etanercept).Today’s decision upholds a prior ruling from the New Jersey District Court, which declared the Amgen patents valid. Sandoz is evaluating its options, which...